Henry D. Tazelaar

29.6k total citations · 3 hit papers
335 papers, 16.8k citations indexed

About

Henry D. Tazelaar is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Henry D. Tazelaar has authored 335 papers receiving a total of 16.8k indexed citations (citations by other indexed papers that have themselves been cited), including 156 papers in Pulmonary and Respiratory Medicine, 117 papers in Surgery and 89 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Henry D. Tazelaar's work include Transplantation: Methods and Outcomes (59 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (54 papers) and Cardiac tumors and thrombi (35 papers). Henry D. Tazelaar is often cited by papers focused on Transplantation: Methods and Outcomes (59 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (54 papers) and Cardiac tumors and thrombi (35 papers). Henry D. Tazelaar collaborates with scholars based in United States, Canada and United Kingdom. Henry D. Tazelaar's co-authors include Jeffrey L. Myers, William D. Edwards, Jay H. Ryu, Thomas V. Colby, Christopher G.A. McGregor, Thomas E. Hartman, Darrell R. Schroeder, James R. Jett, Gerald J. Berry and Samuel A. Yousem and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Henry D. Tazelaar

329 papers receiving 16.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis

1998 796 citations Jay H. Ryu, Mark Edwin et al. American Journal of Respiratory and Critical Care Medicine profile →
Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group.

1996 724 citations Samuel A. Yousem, Henry D. Tazelaar et al. PubMed profile →
The Frequency of Familial Dilated Cardiomyopathy in a Series of Patients with Idiopathic Dilated Cardiomyopathy

1992 495 citations Henry D. Tazelaar et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henry D. Tazelaar United States	71	7.7k	5.1k	4.0k	3.4k	2.5k	335	16.8k
Allen Burke United States	75	8.1k 1.0×	13.1k 2.6×	11.6k 2.9×	3.3k 1.0×	2.5k 1.0×	304	26.9k
Samuel A. Yousem United States	64	6.9k 0.9×	6.9k 1.4×	739 0.2×	3.1k 0.9×	3.0k 1.2×	284	14.4k
Walter Klepetko Austria	72	10.2k 1.3×	5.6k 1.1×	4.0k 1.0×	1.7k 0.5×	2.1k 0.8×	606	18.1k
Douglas B. Cines United States	75	2.9k 0.4×	5.6k 1.1×	1.7k 0.4×	1.6k 0.5×	1.1k 0.4×	357	22.8k
P. Cacoub France	91	6.2k 0.8×	3.8k 0.7×	1.9k 0.5×	10.1k 2.9×	3.8k 1.5×	754	32.3k
Jagdish Butany Canada	59	3.5k 0.5×	3.8k 0.7×	6.6k 1.6×	2.6k 0.8×	850 0.3×	309	12.6k
James E. Loyd United States	65	13.9k 1.8×	2.2k 0.4×	5.0k 1.2×	2.9k 0.8×	962 0.4×	218	18.6k
Steffen Maßberg Germany	73	2.9k 0.4×	5.5k 1.1×	8.0k 2.0×	2.5k 0.7×	1.5k 0.6×	447	21.6k
É. Hachulla France	78	8.3k 1.1×	2.9k 0.6×	1.8k 0.4×	4.6k 1.4×	971 0.4×	677	22.4k
Leslie T. Cooper United States	59	2.0k 0.3×	4.7k 0.9×	14.1k 3.5×	2.4k 0.7×	919 0.4×	219	18.9k

Countries citing papers authored by Henry D. Tazelaar

Since Specialization

Citations

This map shows the geographic impact of Henry D. Tazelaar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry D. Tazelaar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry D. Tazelaar more than expected).

Fields of papers citing papers by Henry D. Tazelaar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry D. Tazelaar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry D. Tazelaar. The network helps show where Henry D. Tazelaar may publish in the future.

Co-authorship network of co-authors of Henry D. Tazelaar

This figure shows the co-authorship network connecting the top 25 collaborators of Henry D. Tazelaar. A scholar is included among the top collaborators of Henry D. Tazelaar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry D. Tazelaar. Henry D. Tazelaar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Maguire, Andrew, Eunhee S. Yi, Yanmei Peng, et al.. (2025). Spatially defined intratumoral immune biomarkers predict recurrent versus second primary tumors in non-small cell lung cancer. Precision Clinical Medicine. 8(1). pbaf001–pbaf001.

Churg, Andrew, Henry D. Tazelaar, Radoslav Matěj, et al.. (2023). Pathologic Criteria for the Diagnosis of Usual Interstitial Pneumonia vs Fibrotic Hypersensitivity Pneumonitis in Transbronchial Cryobiopsies. Modern Pathology. 36(9). 100221–100221. 4 indexed citations

Luca, Alina-Costina, Ingrith Miron, Elena Cojocaru, et al.. (2022). Cardiac Rhabdoid Tumor—A Rare Foe—Case Report and Literature Review. Children. 9(7). 942–942. 3 indexed citations

Luo, Yung‐Hung, Han Liu, Jason A. Wampfler, et al.. (2021). Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation. Journal of Cancer Research and Clinical Oncology. 148(8). 2099–2114. 3 indexed citations

Edwards, William D., et al.. (2004). Heart and Liver Disease in 32 Patients Undergoing Biopsy of Both Organs, With Implications for Heart or Liver Transplantation. Mayo Clinic Proceedings. 79(4). 492–501. 19 indexed citations

Schaefer, Paul, Randolph S. Marks, Michelle R. Mahoney, et al.. (2003). Randomized Phase II Study of Daily Versus Continuous-Infusion Schedules of Topotecan in the Treatment of Extensive-Stage Small Cell Lung Cancers. American Journal of Clinical Oncology. 26(3). 236–240. 9 indexed citations

Blauwet, Lori A., William D. Edwards, Henry D. Tazelaar, & Christopher G.A. McGregor. (2003). Surgical pathology of pulmonary thromboendarterectomy: a study of 54 cases from 1990 to 2001. Human Pathology. 34(12). 1290–1298. 64 indexed citations

Schaefer, Paul, Randolph S. Marks, Michelle R. Mahoney, et al.. (2003). . American Journal of Clinical Oncology. 26(3). 236–240. 1 indexed citations

Allen, Ruth D., et al.. (2003). Surgical pathology of subaortic septal myectomy associated with hypertrophic cardiomyopathy A study of 229 cases. Modern Pathology. 16(1). 55. 18 indexed citations

10.

Douglas, William W., Henry D. Tazelaar, Thomas E. Hartman, et al.. (2001). Polymyositis–Dermatomyositis-associated Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 164(7). 1182–1185. 390 indexed citations

11.

Aubry, Marie‐Christine, et al.. (2000). Pulmonary Lymphangioleiomyomatosis in a Man. American Journal of Respiratory and Critical Care Medicine. 162(2). 749–752. 90 indexed citations

12.

Marrogi, Aizen J., William D. Travis, Judith A. Welsh, et al.. (2000). Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma.. PubMed. 6(12). 4739–44. 184 indexed citations

13.

Egan, Michael, Lisa A. Boardman, Henry D. Tazelaar, et al.. (1999). Erdheim-Chester Disease. The American Journal of Surgical Pathology. 23(1). 17–26. 115 indexed citations

14.

Ryu, Jay H., Mark Edwin, Jeffrey L. Myers, et al.. (1998). Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 157(1). 199–203. 796 indexed citations breakdown →

15.

Maksymiuk, Andrew W., Robert F. Marschke, Henry D. Tazelaar, et al.. (1998). Phase II Trial of Topotecan for the Treatment of Mesothelioma. American Journal of Clinical Oncology. 21(6). 610–613. 24 indexed citations

16.

Fleming, Marian V., Donald G. Guinee, Andrew N. Freedman, et al.. (1998). Bcl-2 immunohistochemistry in a surgical series of non-small cell lung cancer patients. Human Pathology. 29(1). 60–64. 34 indexed citations

17.

Burke, Louise, Khan Ma, Andrew N. Freedman, et al.. (1998). Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.. PubMed. 58(12). 2533–6. 65 indexed citations

18.

Tazelaar, Henry D., et al.. (1989). Bronchocentric Mycosis Occurring in Transplant Recipients. CHEST Journal. 96(1). 92–95. 36 indexed citations

19.

Tazelaar, Henry D., Jochum Prop, Paul Nieuwenhuis, Margaret E. Billingham, & Charles R.H. Wildevuur. (1988). AIRWAY PATHOLOGY IN THE TRANSPLANTED RAT LUNG. Transplantation. 45(5). 864–868. 44 indexed citations

20.

Prop, Jochum, Henry D. Tazelaar, & Margaret E. Billingham. (1987). Rejection of combined heart-lung transplants in rats. Function and pathology.. PubMed Central. 127(1). 97–105. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact